Napabucasin: An Update on the First-in-Class Cancer Stemness Inhibitor von Hubbard, Joleen M., Grothey, Axel

Volltext

The Imperative for a New Approach to Toxicity Analysis in Oncology Clinical Trials von Thanarajasingam, Gita, Hubbard, Joleen M, Sloan, Jeff A, Grothey, Axel

Volltext

Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resect... von Katz, Matthew H G, Ou, Fang-Shu, Herman, Joseph M, Ahmad, Syed A, Wolpin, Brian, Marsh, Robert, Behr, Spencer, Shi, Qian, Chuong, Michael, Schwartz, Lawrence H, Frankel, Wendy, Collisson, Eric, Koay, Eugene J, Hubbard, JoLeen M, Leenstra, James L, Meyerhardt, Jeffrey, O'Reilly, Eileen

Volltext

Patient and Tumor Characteristics and BRAF and KRAS Mutations in Colon Cancer, NCCTG/Alliance N0147 von GONSALVES, Wilson I, MAHONEY, Michelle R, HUBBARD, Joleen M, CHAN, Emily, NAIR, Suresh, BERENBERG, Jeffrey L, MCWILLIAMS, Robert R, SARGENT, Daniel J, NELSON, Garth D, ALBERTS, Steven R, SINICROPE, Frank A, GOLDBERG, Richard M, LIMBURG, Paul J, THIBODEAU, Stephen N, GROTHEY, Axel

Volltext

Characterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical Trials von Duma, Narjust, Kothadia, Sejal M, Azam, Tariq U, Yadav, Siddhartha, Paludo, Jonas, Vera Aguilera, Jesus, Gonzalez Velez, Miguel, Halfdanarson, Thorvardur Ragnar, Molina, Julian R, Hubbard, Joleen M, Go, Ronald S, Mansfield, Aaron S, Adjei, Alex A

Volltext

Novel Methylated DNA Markers in the Surveillance of Colorectal Cancer Recurrence von Xie, Hao, Mahoney, Douglas W., Foote, Patrick H., Burger, Kelli N., Doering, Karen A., Taylor, William R., Then, Sara S., Cao, Xiaoming, McGlinch, Maria, Berger, Calise K., Wu, Tsung-Teh, Hubbard, Joleen M., Allawi, Hatim T., Kaiser, Michael W., Lidgard, Graham P., Ahlquist, David A., Kisiel, John B.

Volltext

Lack of Caudal-Type Homeobox Transcription Factor 2 Expression as a Prognostic Biomarker in Metastatic Colorectal Cancer von Zhang, Ben Y., Jones, Jeremy C., Briggler, Andrew M., Hubbard, Joleen M., Kipp, Benjamin R., Sargent, Daniel J., Dixon, Jesse G., Grothey, Axel

Volltext

Comparing Oncologic Outcomes and Toxicity for Combined Modality Therapy vs. Carbon-Ion Radiotherapy for Previously Irradiated Locally Recurrent Rectal Cancer von Jeans, Elizabeth B, Ebner, Daniel K, Takiyama, Hirotoshi, Qualls, Kaitlin, Cunningham, Danielle A, Waddle, Mark R, Jethwa, Krishan R, Harmsen, William S, Hubbard, Joleen M, Dozois, Eric J, Mathis, Kellie L, Tsuji, Hiroshi, Merrell, Kenneth W, Hallemeier, Christopher L, Mahajan, Anita, Yamada, Shigeru, Foote, Robert L, Haddock, Michael G

Volltext

The prognostic value of CD3+ tumor-infiltrating lymphocytes for stage II colon cancer according to use of adjuvant chemotherapy: A large single-institution cohort study von Francini, Edoardo, Ou, Fang-Shu, Lazzi, Stefano, Petrioli, Roberto, Multari, Andrea G., Pesola, Guido, Messuti, Luciana, Colombo, Elena, Livellara, Virginia, Bazzurri, Serena, Cherri, Sara, Miano, Salvatora T., Wolfe, Eric G., Alberts, Steven R., Hubbard, Joleen M., Yoon, Harry H., Francini, Guido

Volltext

Dual VEGF inhibition with sorafenib and bevacizumab as salvage therapy in metastatic colorectal cancer: results of the phase II North Central Cancer Treatment Group study N054C (Al... von Xie, Hao, Lafky, Jacqueline M., Morlan, Bruce W., Stella, Philip J., Dakhil, Shaker R., Gross, Gerald G., Loui, William S., Hubbard, Joleen M., Alberts, Steven R., Grothey, Axel

Volltext

Non-V600 BRAF Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal Cancer von Jones, Jeremy C, Renfro, Lindsay A, Al-Shamsi, Humaid O, Schrock, Alexa B, Rankin, Andrew, Zhang, Ben Y, Kasi, Pashtoon M, Voss, Jesse S, Leal, Alexis D, Sun, James, Ross, Jeffrey, Ali, Siraj M, Hubbard, Joleen M, Kipp, Benjamin R, McWilliams, Robert R, Kopetz, Scott, Wolff, Robert A, Grothey, Axel

Volltext

Cases in the management of metastatic colorectal cancer: rechallenge with chemotherapy after regorafenib in a patient with RAS/BRAF wild-type disease von Hubbard, Joleen M

Volltext

Incorporating biomarkers of frailty and senescence in cancer therapeutic trials von Hubbard, Joleen M, Jatoi, Aminah

Volltext

Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2... von Strickler, John H, Cercek, Andrea, Siena, Salvatore, André, Thierry, Ng, Kimmie, Van Cutsem, Eric, Wu, Christina, Paulson, Andrew S, Hubbard, Joleen M, Coveler, Andrew L, Fountzilas, Christos, Kardosh, Adel, Kasi, Pashtoon M, Lenz, Heinz-Josef, Ciombor, Kristen K, Elez, Elena, Bajor, David L, Cremolini, Chiara, Sanchez, Federico, Stecher, Michael, Feng, Wentao, Bekaii-Saab, Tanios S, Van Cutsem, Eric, Peeters, Marc, Van den Evnde, Marc, André, Thierry, Borg, Christophe, Sarabi, Matthieu, Ghiringhelli, Francois, Chibaudel, Benoist, Siena, Salvatore, Cremolini, Chiara, Zampino, Maria G., Elez, Elena, Keranen, Susana R., Salazar, Ramon, Alfonso, Pilar, Strickler, John H., Cercek, Andrea, Ng, Kimmie, Wu, Christina, Paulson, Andrew S., Hubbard, Joleen M., Coveler, Andrew L., Fountzilas, Christos, Kardosh, Adel, Kasi, Pashtoon M., Lenz, Heinz-Josef, Ciombor, Kristen K., Bajor, David L., Bekaii-Saab, Tanios S., Gbolahan, Olumide, Boland, Patrick, Berg, Daniel, Sanchez, Federico, Goggins, Timothy, Saeed, Anwar, Burris, Howard, Bendell, Johanna, Outlaw, Darryl, Tafur, Isaac, Shergill, Ardaman, Catenacci, Daniel, Gong, Jun, Garrido-Laguna, Ignacio, Finley, Gene, Weinberg, Benjamin, Shields, Anthony, Philip, Philip, Turk, Anita, Nguyen, Anthony, Braiteh, Fadi, Patel, Vijay, Harwin, William, Anderson, Ian, Kundra, Ajay, Chen, Christopher, Ford, James, Kundranda, Madappa, Nguyen, Danny, Ratnam, Suresh, Richards, Donald, Nallapareddy, Sujatha, Beeram, Sridhar, McKenney, Scott, Shao, Spencer

Volltext

Management of Non-Colorectal Digestive Cancers with Microsatellite Instability von Zhu, Mojun, Jin, Zhaohui, Hubbard, Joleen M.

Volltext

Incorporating biomarkers into cancer and aging research von Hubbard, Joleen M, Cohen, Harvey J, Muss, Hyman B

Volltext

The Management of Older Adults with Pancreatic Adenocarcinoma von Ogden, John R, Xie, Hao, Ma, Wen Wee, Hubbard, Joleen M

Volltext

Intensity modulated radiotherapy for anal canal squamous cell carcinoma: A 16-year single institution experience von Jethwa, Krishan R., Day, Courtney N., Sandhyavenu, Harigopal, Gonuguntla, Karthik, Harmsen, William S., Breen, William G., Routman, David M., Garda, Allison E., Hubbard, Joleen M., Halfdanarson, Thorvardur R., Neben-Wittich, Michelle A., Merrell, Kenneth W., Hallemeier, Christopher L., Haddock, Michael G.

Volltext

When less is more: maintenance therapy in colorectal cancer von Hubbard, Joleen M, Grothey, Axel

Volltext

Colorectal cancer: how emerging molecular understanding affects treatment decisions von Sridharan, Meera, Hubbard, Joleen M, Grothey, Axel

Volltext